Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Prophylaxis of deep venous thrombosis with a low-molecular-weight heparin (Kabi 2165/Fragmin) in stroke patients.

Prins MH, Gelsema R, Sing AK, van Heerde LR, den Ottolander GJ.

Haemostasis. 1989;19(5):245-50.

PMID:
2550335
2.

A double-blind and randomized placebo-controlled trial of low molecular weight heparin once daily to prevent deep-vein thrombosis in acute ischemic stroke.

Sandset PM, Dahl T, Stiris M, Rostad B, Scheel B, Abildgaard U.

Semin Thromb Hemost. 1990 Oct;16 Suppl:25-33.

PMID:
1962901
3.

[Evaluation of the effectiveness and safety of Fragmin (Kabi 2165) versus calcium heparin in the prevention of deep venous thrombosis in general surgery].

Creperio G, Marabini M, Ciocia G, Bergonzi M, Fincato M.

Minerva Chir. 1990 Sep 15;45(17):1101-6. Italian.

PMID:
2177861
4.

Randomized trial of a low-molecular-weight heparin (Kabi 2165) versus adjusted-dose subcutaneous standard heparin in the prophylaxis of deep-vein thrombosis after elective hip surgery.

Dechavanne M, Ville D, Berruyer M, Trepo F, Dalery F, Clermont N, Lerat JL, Moyen B, Fischer LP, Kher A, et al.

Haemostasis. 1989;19(1):5-12.

PMID:
2537787
7.

Low dose heparin versus low molecular weight heparin (Kabi 2165, Fragmin) in the prophylaxis of thromboembolic complications of abdominal oncological surgery.

Fricker JP, Vergnes Y, Schach R, Heitz A, Eber M, Grunebaum L, Wiesel ML, Kher A, Barbier P, Cazenave JP.

Eur J Clin Invest. 1988 Dec;18(6):561-7.

PMID:
2852111
8.
11.

Prophylaxis of venous thromboembolism in stroke patients.

Turpie AG.

Semin Thromb Hemost. 1997;23(2):155-7.

PMID:
9200340
12.

Two daily subcutaneous injections of fragmin as compared with intravenous standard heparin in the treatment of deep venous thrombosis (DVT).

Bratt G, Aberg W, Johansson M, Törnebohm E, Granqvist S, Lockner D.

Thromb Haemost. 1990 Dec 28;64(4):506-10.

PMID:
1964751
13.

[The thromboprophylactic effect of low molecular weight heparin (Fragmin) in hip fracture surgery. A placebo controlled trial].

Jørgensen PS, Knudsen JB, Broeng L, Josephsen IL, Bjerregaard P, Hagen KK, Jørgensen PK, Tørholm C.

Ugeskr Laeger. 1993 Mar 8;155(10):706-8. Danish.

PMID:
8384388
14.

A low molecular weight heparin (KABI 2165) for prophylaxis of postoperative deep venous thrombosis.

Onarheim H, Lund T, Heimdal A, Arnesjø B.

Acta Chir Scand. 1986 Oct;152:593-6.

PMID:
3544625
15.

Orgaran in the prevention of deep vein thrombosis in stroke patients.

Turpie AG.

Haemostasis. 1992;22(2):92-8. Review.

PMID:
1379969
16.
17.
18.

A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty.

Freedman KB, Brookenthal KR, Fitzgerald RH Jr, Williams S, Lonner JH.

J Bone Joint Surg Am. 2000 Jul;82-A(7):929-38.

PMID:
10901307
19.

[Treatment of deep venous thrombosis. Comparative study of a low molecular weight heparin fragment (Fragmin) by the subcutaneous route and standard heparin by the continuous intravenous route. A multicenter study].

Aiach M, Fiessinger JN, Vitoux JF, Derlon A, Grollier G, Le Querrec A, Gouault-Heilmann M, Huet Y, Franco A, Polack B, Pouzol P, Dubois A, Schved JF, Boneu B, Guittard J, Sie P, Heilmann JJ, Kher A, Haye I.

Rev Med Interne. 1989 Jul-Aug;10(4):375-81. French.

PMID:
2552552
20.

A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery.

Nurmohamed MT, Verhaeghe R, Haas S, Iriarte JA, Vogel G, van Rij AM, Prentice CR, ten Cate JW.

Am J Surg. 1995 Jun;169(6):567-71.

PMID:
7771617

Supplemental Content

Support Center